(Press-News.org) Age-related macular degeneration (AMD) is a major cause of blindness, especially in older adults. A key feature of early AMD is the formation of drusen, clumps of debris made of lipids and proteins that collect between two layers at the back of the eye — the retinal pigment epithelium (RPE) and Bruch’s membrane (BrM).
These drusen are not just signs of the disease; they actively contribute to vision loss by damaging the retina above them. Scientists suspect that lipoproteins — fat-protein complexes like high density lipoprotein (HDL) — play a big role in forming drusen. However, it wasn’t clear why these lipoproteins get stuck in BrM in the first place.
This study, published today in Proceedings of the National Academy of Sciences (PNAS) and led by Christopher B. Toomey, M.D., Ph.D., an assistant professor of ophthalmology at the Shiley Eye Institute, Viterbi Family Department of Ophthalmology, UC San Diego School of Medicine, suggests that heparan sulfate (HS) in BrM is a major player in early AMD by trapping lipoproteins and kickstarting drusen formation. Targeting this sticky interaction might be a way to prevent or even reverse early signs of AMD before vision loss occurs.
Findings of the study:
AMD patients had significantly more HS in the macular area of BrM than those without AMD.
Lipoprotein-like particles (like HDL) clustered in areas rich in HS — suggesting HS may physically trap these particles.
When the researchers treated AMD tissue with heparin (a compound similar to HS), they were able to wash out these lipoproteins. This confirmed that the particles were indeed sticking to the HS.
Lipoproteins showed strong binding to BrM, but only if the HS was intact. When HS was removed, or when they added special heparin-like molecules, the binding stopped. This suggests it may be possible to prevent or reverse lipoprotein buildup in BrM using therapeutic agents that interfere with this interaction.
The study also shows the promise of non-blood-thinning forms of heparin as potential treatments. These could help “wash away” harmful lipids without the bleeding risks of regular heparin.
# # #
END
Research alert: laying the groundwork for potential age-related macular degeneration therapies
2025-06-09
ELSE PRESS RELEASES FROM THIS DATE:
It’s not the game, it’s the group: Sports fans connect the most over rituals
2025-06-09
University of Connecticut professor of anthropology Dimitris Xygalatas is a scientist and self-declared rational thinker. But he’s also a lifelong soccer fan, and he fully admits that when his Greek home team finally won their league in 2019, he cried tears of joy.
“Not what you might call a rational organism’s behavior,” he jokes.
But his reaction is in keeping with his latest study, to be published online Monday, June 9, in the Proceedings of the National Academy of Sciences, which shows that the intense feelings of joy, ...
AI identifies key gene sets that cause complex diseases
2025-06-09
Northwestern University biophysicists have developed a new computational tool for identifying the gene combinations underlying complex illnesses like diabetes, cancer and asthma.
Unlike single-gene disorders, these conditions are influenced by a network of multiple genes working together. But the sheer number of possible gene combinations is huge, making it incredibly difficult for researchers to pinpoint the specific ones that cause disease.
Using a generative artificial intelligence (AI) model, the new method amplifies limited gene expression data, enabling ...
Virginia Tech study sheds light on solar farm impacts to property values
2025-06-09
As solar energy becomes more affordable and widespread, farmland has emerged as a prime location for large-scale solar development. But with this expansion comes a persistent question: Do nearby property values suffer when solar farms move in?
In a new paper published in the Proceedings of the National Academy of Sciences, researchers in Virginia Tech’s Department of Agricultural and Applied Economics in the College of Agriculture and Life Sciences looked at millions of property sales and thousands of commercial solar sites to shed some light on one of the mostly commonly cited downsides of large-scale solar adoption.
“As the ...
Study defines key driver of aggressive ovarian cancer
2025-06-09
ANN ARBOR, Michigan — A new study explains the genetic underpinnings of a rare and aggressive form of ovarian cancer – and offers a potential pathway for new treatments.
High-grade serous carcinoma, the most common type of ovarian cancer, usually begins in the fallopian tube, before spreading to the ovaries and other pelvic organs. The cancer is typically discovered at an advanced stage and becomes resistant to current chemotherapies. Its underlying genetics are complex, with multiple genetic alterations and instabilities. One of the genes involved is CDK12.
In this new study, published in the Proceedings ...
Rings of time: unearthing climate secrets from ancient trees
2025-06-09
Deep in the swamps of the American Southeast stands a quiet giant: the bald cypress (Taxodium distichum). These majestic trees, with their knobby “knees” and towering trunks, are more than just swamp dwellers – they’re some of the oldest living organisms in Eastern North America. Some have been around for more than 2,500 years, quietly thriving in nutrient-poor, flooded forests where most other trees would wither.
But life isn’t easy for these ancient trees. They’re under siege ...
Medical AI systems failing to disclose inaccurate race, ethnicity information
2025-06-09
The inaccuracy of race and ethnicity data found in electronic health records (EHRs) can negatively impact patient care as artificial intelligence (AI) is increasingly integrated into healthcare. Because hospitals and providers inconsistently collect such data and struggle to accurately classify individual patients, AI systems trained on these datasets can inherit and perpetuate racial bias.
In a new publication in PLOS Digital Health, experts in bioethics and law call for immediate standardization of methods for collection of race and ethnicity data, and for developers to warranty race and ethnicity data quality in medical AI systems. The research synthesizes concerns about why patient ...
Light and AI drive precise motion in soft robotic arm developed at Rice
2025-06-09
HOUSTON – (June 9, 2025) – Researchers at Rice University have developed a soft robotic arm capable of performing complex tasks such as navigating around an obstacle or hitting a ball, guided and powered remotely by laser beams without any onboard electronics or wiring. The research could inform new ways to control implantable surgical devices or industrial machines that need to handle delicate objects.
In a proof-of-concept study that integrates smart materials, machine learning and an optical control system, a team of Rice researchers led by materials scientist Hanyu Zhu used a light-patterning device to ...
Vital connections between journalists and whistleblowers under increasing pressure
2025-06-09
Investigative journalists are facing severe challenges and threats, and their vital connections with whistleblowers are under increasing pressure, researchers have said.
Legal intimidation is having a "chilling effect" and those engaged in crime and security journalism are encountering extreme risks.
Experts have discussed their significant concerns about the perils many journalists face in their commitment to uncovering truth, from pervasive state surveillance to targeted prosecution and even espionage ...
Patients are opting in for 10 years of breast cancer treatment
2025-06-09
ANN ARBOR, Michigan — As recommendations suggest extending hormone-based breast cancer treatment to 10 years for some patients, a new study sheds light on whether patients are opting for it.
In a study of 591 women with early stage breast cancer who completed five years of endocrine therapy, 47% decided to continue the treatment. Patients with stage 2 disease were more likely to continue, with 62% agreeing, compared to 39% of patients with stage 1 cancer.
The study, led by researchers at the University of Michigan Rogel Cancer Center and Stanford Medicine, was published in the Journal of the National Cancer Institute.
Endocrine ...
Center for Bioenergy Innovation taps Cregger, Eckert as chief science officers
2025-06-09
The Center for Bioenergy Innovation, or CBI, at the Department of Energy’s Oak Ridge National Laboratory has promoted Melissa Cregger and Carrie Eckert to serve as chief science officers, advancing the center’s mission of innovations for new domestic biofuels, chemicals and materials.
Cregger will oversee CBI’s development of resilient, high-yielding, non-food feedstock crops, while Eckert will guide the center’s research on cost-effective methods to break down and convert plant biomass into valuable fuels and products.
Brian Davison, chief scientist for biotechnology at ORNL and formerly chief science officer for the center, ...